Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/DEFENCE-THERAPEUTICS-INC-122508759/news/Defence-Therapeutics-Inc-gibt-die-erfolgreiche-Erprobung-des-Anti-Krebs-Impfstoffs-der-zweiten-Gene-46326232/?utm_source=whatsapp&utm_medium=social&utm_campaign=share